Comparison of MS outcomes after Switching to Natalizumab versus staying on Interferon-beta or glatiramer

Spelman T., Izquierdo G., Lugaresi A., Alroughani R., Duquette P., Boz C., ...More

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, vol.22, pp.600-602 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 22
  • City: London
  • Country: Canada
  • Page Numbers: pp.600-602
  • Karadeniz Technical University Affiliated: Yes